Panavance Therapeutics Inc.

About Panavance Therapeutics Inc.

Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to ...

^{( I )}

Panavance Therapeutics Inc. Company Information

Phone Number

610.922.1910

Corporate Office Address

1055 Westlakes Drive
Berwyn, 19312

Website

Industry

Pharmaceuticals

Number of Employees

11 - 50 Employees

Company Revenue

$5M - $20M

Find Company Contacts

Is this company information helpful?

Panavance Therapeutics Inc. Org

Find Decision Makers

Panavance Therapeutics Inc.'s Tech Stack

Cdnjs

Cloudflare

Contact Form

CookieYes

View More Technologies

Frequently Asked Questions About
Panavance Therapeutics Inc.

Frequently Asked Questions About
Panavance Therapeutics Inc.

Who is Panavance Therapeutics Inc.'s CEO?

Panavance Therapeutics Inc.'s CEO is Greg Bosch

Where is the Panavance Therapeutics Inc. headquarters?

Panavance Therapeutics Inc.'s HQ is located at 1055 Westlakes Drive, Berwyn

What is the Panavance Therapeutics Inc.'s main phone number?

Panavance Therapeutics Inc.'s phone number is 610.922.1910

What is the Panavance Therapeutics Inc.'s official website?

Panavance Therapeutics Inc.'s official website is panavance.com

What is Panavance Therapeutics Inc.'s Revenue?

Panavance Therapeutics Inc.'s revenue is $5M - $20M

How many employees are working in Panavance Therapeutics Inc.?

Panavance Therapeutics Inc. has 11 - 50 employees

What industry is the Panavance Therapeutics Inc. in?

Panavance Therapeutics Inc. is in the industry of: Pharmaceuticals

About Panavance Therapeutics Inc.

Seamless Pro Tip